Schematic representation of option 2, by which some patients are offered treatment by allo-SCT soon after diagnosis if they are young and have a suitable donor.

Others are deemed ineligible for allo-SCT. The intermediate group is offered initial treatment with STI571 and may proceed to allo-SCT if the trial of STI571 is deemed to have failed. A/G indicates autografting.